TG Therapeutics shares made new 52-week highs this week, helped in part by new Briumvi data presentations at ECTRIMS. Find ...

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

The FDA has approved FluMist nasal spray as the first at-home flu vaccine. People aged 18 and older can now self-administer ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...

The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...

Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...